Sponsor of the Day:
Jerkmate
https://akerotx.com/publications-posters/
Akero Therapeutics | Efruxifermin for MASH | Publications
Feb 26, 2026 - Akero Therapeutics is a clinical-stage company developing transformational therapies for people with metabolic dysfunction-associated steatohepatitis (MASH).
akero therapeuticsmashpublications
https://akerotx.com/job-opportunities/
Akero Therapeutics | EFX for MASH | Job Opportunities
Aug 28, 2025 - See job openings at Akero, a clinical-stage company developing transformation treatments for metabolic dysfunction-associated steatohepatitis (MASH).
akero therapeuticsjob opportunitiesefxmash
https://akerotx.com/
Akero Therapeutics | EFX for MASH | Metabolic Disease | Home
Dec 5, 2025 - Akero Therapeutics is a clinical-stage company developing transformational therapies for people with metabolic dysfunction-associated steatohepatitis (MASH).
akero therapeuticsmetabolic diseaseefxmash